Stanford University
Showing 1,251-1,300 of 2,473 Results
-
Michael Levitt
Robert W. and Vivian K. Cahill Professor of Cancer Research
Current Research and Scholarly InterestsStanford Professor of Biophysics and Computational Biology, Cambridge PhD and DSc, 2013 Chemistry Nobel Laureate (complex systems), FRS & US National Academy member, I code well for my age.
-
Indra Levy
Associate Professor of East Asian Languages and Cultures, by courtesy of Comparative Literature and Senior Fellow, by courtesy, at the Freeman Spogli Institute for International Studies
BioIndra Levy received her Ph.D. in modern Japanese literature from Columbia University in 2001. She is the author of Sirens of the Western Shore: the Westernesque Femme Fatale, Translation, and Vernacular Style in Modern Japanese Literature (Columbia, 2006) and editor of Translation in Modern Japan (Routledge, 2009). She has served as Executive Director for the Inter-University Center for Japanese Language Studies (IUC) since 2010. In 2022, she was named the inaugural recipient of the Irene Hirano Inouye Award from the Terasaki Center for Japanese Studies for her contributions to Japanese Studies. Her current work focuses on humor in Japanese literature, performance, and translation from the late 19th century to the mid-20th. Her research interests include modern Japanese literature and criticism; critical translation studies; gender and language; modern Japanese performance, especially in the Meiji and Taishō eras; and modern Japanese women’s intellectual history.
-
Maayan Levy
Associate Professor of Pathology
Current Research and Scholarly InterestsThe Levy Lab studies how microbiome-brain interactions influence metabolism, behavior, and disease. By investigating how microbial signals affect neural circuits, we explore mechanisms underlying obesity, diabetes, and psychiatric conditions. The lab seeks to uncover new therapeutic targets using advanced neuroscience tools like optogenetics and imaging. Our research aims to improve understanding of how microbiome imbalances contribute to disease and how restoring balance can promote health.
-
Ronald Levy, MD
Robert K. and Helen K. Summy Professor in the School of Medicine
Current Research and Scholarly InterestsClinical Interests: lymphoma. Research Interests: Immunology and molecular biology of lymphoid malignancy; molecular vaccines for cancer.
-
Adrian Lew
Professor of Mechanical Engineering
BioProf. Lew's interests lie in the broad area of computational solid mechanics. He is concerned with the fundamental design and mathematical analysis of material models and numerical algorithms.
Currently the group is focused on the design of algorithms to simulate hydraulic fracturing. To this end we work on algorithms for time-integration embedded or immersed boundary methods. -
Richard Lewis
Professor of Molecular and Cellular Physiology, Emeritus
Current Research and Scholarly InterestsWe study molecular mechanisms of calcium signaling with a focus on store-operated CRAC channels and their essential roles in T cell development and function. Currently we aim to define the molecular mechanism for CRAC channel activation and the means by which calcium signal dynamics mediate specific activation of transcription factors and T-cell genes during development.
-
Fei-Fei Li
Sequoia Capital Professor, Senior Fellow at HAI and Professor, by courtesy, of Operations, Information and Technology at the Graduate School of Business
Current Research and Scholarly InterestsAI, Machine Learning, Computer Vision, Robotics, AI+Healthcare, Human Vision
-
Gordon Li, MD
Professor of Neurosurgery and, by courtesy, of Neurology and Neurological Sciences and of Otolaryngology - Head & Neck Surgery (OHNS)
Current Research and Scholarly Interests1.) My laboratory studies the biology of brain tumors with the goal of developing novel therapeutics for the treatment of malignant brain tumors and translating that research into clinical trials.
2.) My clinical interests include improving surgical techniques for brain tumor surgery, immunotherapy for the treatment of glioblastoma, and novel uses for stereotactic radiosurgery. -
Jin Billy Li
Professor of Genetics
Current Research and Scholarly InterestsThe Li Lab is primarily interested in RNA editing mediated by ADAR enzymes. We co-discovered that the major function of RNA editing is to label endogenous dsRNAs as "self" to avoid being recognized as "non-self" by MDA5, a host innate immune dsRNA sensor, leading us to pursue therapeutic applications in cancer, autoimmune diseases, and viral infection. The other major direction of the lab is to develop technologies to harness endogenous ADAR enzymes for site-specific transcriptome engineering.
-
Lingyin Li
Professor of Biochemistry
Current Research and Scholarly InterestsUnderstanding and targeting the cGAS-cGAMP-STING pathway for the treatment of cancer and autoimmunity.
-
Minxing Li
Senior Licensing and Strategic Alliances Manager, Life Sciences, Office of Technology Licensing (OTL)
BioMinxing is a Licensing and Strategic Alliances Manager at Stanford OTL with a focus on life sciences technologies. Since she joined Stanford in 2020, she has been involved in protecting, marketing and licensing of Stanford's intellectual property. She is currently responsible for managing Stanford's alliances with the Parker Institute for Cancer Immunotherapy (PICI), where she works closely with investigators who are part of the PICI network and manages IP and licensing matters under the PICI relationship.
Prior to Stanford, Minxing worked as a consultant at IQVIA, Inc. -
Ron Li
Clinical Associate Professor, Medicine
BioRon Li is a Clinical Associate Professor of Medicine in the Division of Hospital Medicine and Center for Biomedical Informatics Research at Stanford University School of Medicine. As the Medical Informatics Director for Digital Health at Stanford Health Care, he provides medical and informatics direction for the health system's enterprise digital health portfolio, including expanding digital referral networks and virtual care modalities. He is also the founding Medical Director for Stanford Health Care at Home and the co-founder and Director for the Stanford Emerging Applications Lab (SEAL), which helps clinicians and staff build ideas into novel digital products that are prototyped and tested for care delivery at Stanford Health Care.
Ron's academic interests focus on the "delivery science" of new technological capabilities such as digital and artificial intelligence in healthcare and how to design, implement, and evaluate new tech enabled models of care delivery. Ron's work spans across multiple disciplines, including clinical medicine, data science, digital health, information technology, design thinking, process improvement, and implementation science. He has consulted for various companies in the digital health and artificial intelligence space. He is an attending physician on the inpatient medicine teaching service at Stanford Hospital and is the Associate Program Director for the Stanford Clinical Informatics Fellowship. -
Ruijiang Li
Associate Professor of Radiation Oncology (Radiation Physics)
Current Research and Scholarly InterestsMy lab's research is focused on the development of imaging and molecular biomarkers to improve cancer detection, diagnosis, prognostication, and prediction of therapy response. Our ultimate goal is to translate these biomarkers into clinical practice to guide optimal management and therapeutic decisions for precision cancer medicine.
-
Shanjun Li
Steven and Roberta Denning Global Sustainability Professor, Senior Fellow at the Freeman Spogli Institute for International Studies, at the Stanford Institute for Economic Policy Research, and at the Precourt Institute for Energy
BioShanjun Li is the Steven and Roberta Denning Global Sustainability Professor and a Senior Fellow at both the Freeman Spogli Institute for International Studies (FSI) and the Stanford Institute for Economic Policy Research (SIEPR). His research focuses on environmental and energy economics, urban and transportation economics, empirical industrial organization, and the Chinese economy. His recent work examines pressing sustainability challenges and the rapid rise of clean energy industries in China, exploring their global implications to inform evidence-based policymaking.
-
Jiahao Liang
Ph.D. Student in Molecular and Cellular Physiology, admitted Autumn 2020
OTL Intern, Office of Technology Licensing (OTL)BioI'm currently a 6th-year Ph.D. student in Molecular & Cellular Physiology and an intern at the Office of Technology Licensing. I study how the spatial organization and structural conformation of synaptic proteins regulate synaptic transmission.
-
Percy Liang
Professor of Computer Science and Senior Fellow at the Stanford Institute for Human-Centered AI
BioPercy Liang is an Associate Professor of Computer Science at Stanford University (B.S. from MIT, 2004; Ph.D. from UC Berkeley, 2011) and the director of the Center for Research on Foundation Models (CRFM). He is currently focused on making foundation models (in particular, language models) more accessible through open-source and understandable through rigorous benchmarking. In the past, he has worked on many topics centered on machine learning and natural language processing, including robustness, interpretability, human interaction, learning theory, grounding, semantics, and reasoning. He is also a strong proponent of reproducibility through the creation of CodaLab Worksheets. His awards include the Presidential Early Career Award for Scientists and Engineers (2019), IJCAI Computers and Thought Award (2016), an NSF CAREER Award (2016), a Sloan Research Fellowship (2015), a Microsoft Research Faculty Fellowship (2014), and paper awards at ACL, EMNLP, ICML, COLT, ISMIR, CHI, UIST, and RSS.
-
Joseph C. Liao
Kathryn Simmons Stamey Professor
Current Research and Scholarly InterestsThe overarching theme of my scholarship is to develop precision diagnostics in imaging and biomarkers to guide the delivery of precision therapy for urological diseases including bladder cancer, urinary tract infections, and kidney stone disease.
-
Ronglih Liao
Douglass M. and Nola Leishman Professor of Cardiovascular Disease
BioDr. Liao is a Professor of Medicine and co-Director of Stanford Cardiac Amyloid Center. The major goal of her research program focuses on understanding the mechanisms that underlie the pathophysiology of heart failure and developing novel treatments to combat this process. Her laboratory has played an international leading role in the study of amyloid light chain (AL) cardiomyopathy, a rare and fatal form of cardiovascular disease. We have described the underlying pathophysiologic basis for amyloid cardiomyopathy and found that the circulating amyloidogenic light chain proteins that characterize this disease directly result in a specific cardiotoxic response. Consequently, our research work has redefined AL cardiomyopathy and has raised new treatment approaches. More recently, her research efforts have expanded to include transthyretin (ATTR) cardiac amyloidosis.
In line with her goal of revealing novel therapeutic strategies for patients with cardiovascular disease, our efforts have also focused on characterizing and harnessing endogenous cardiac regenerative mechanisms. Her laboratory initially demonstrated the therapeutic potential of exogenous primitive muscle cells delivered to the injured heart. This work was among the earliest milestones in the field and served as the basis for an international trial of cell-based therapy. Subsequently, Liao lab identified and characterized a population of cardiac progenitor cells and its relationship and dynamic activity following cardiac injury in the adult heart. Her laboratory aims to reveal the molecular mechanisms regulating the endogenous regenerative capacity of the heart and to harness such repair mechanisms for the treatment of cardiovascular disease. Dr. Liao has lectured extensively on both amyloid cardiomyopathy and stem cell biology, and have maintained a history of independent NIH funding in these areas for more than two decades.
Over the course of her academic career, she has taken the greatest pride in mentoring the next generation of scientists. Dr. Liao has had the privilege to supervise several dozen students, postdoctoral fellows, and junior faculty, many of whom have gone on to independent academic careers at the highest institutions. Her contribution to the advancement of scientific knowledge also includes lecturing at various university and academic institutions as well as at scores of conferences and symposia locally, nationally, and internationally. -
Y. Joyce Liao, MD, PhD
Stanford Medicine Professor of Ophthalmology and Professor of Neurology and Neurological Sciences
Current Research and Scholarly InterestsIschemic optic neuropathy
Stem cell transplantation
Optic neuropathy
Optic neuritis
Eye movement disorders
Reading
Parkinson's disease
Multiple sclerosis -
Leticia Liggett
Industrial Contracts Officer-Floater, Office of Technology Licensing (OTL)
BioLeticia is an Industrial Contracts Officer in Stanford’s Office of Technology Licensing. Before joining Stanford, Leticia was a Research Contract Officer at Indiana University and a Conflict of Interest Analyst at the University of Arizona. She has also practiced as a legal aid attorney. Prior to practicing law, she was an instructor of college writing and literature courses.
Education
Ph.D., Indiana University, Bloomington, English Literature
J.D./LL.M. (Intellectual Property), University of New Hampshire Franklin Pierce School of Law
M.A., Butler University, Literature
B.A., DePauw University, English Literature -
Theresa Lii, M.D., M.S.
Instructor, Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsEvaluating ketamine for chronic pain: dosing, predictors, and opioid outcomes
-
Eunjung Lim
Affiliate, FSI - S-APARC
Visiting Scholar, FSI - S-APARCBioEunjung Lim is a Professor in the Division of International Studies at Kongju National University (KNU). She is a Visiting Scholar at the Shorenstein Asia-Pacific Research Center, Stanford University (April 2026–February 2027).
Her research focuses on international cooperation in the Indo-Pacific, comparative and global governance, and energy, nuclear, and climate change policies in East Asia. She previously served as a board member of the Korea Institute of Nuclear Nonproliferation and Control (KINAC) from May 2018 to July 2024 and currently serves on the Policy Advisory Committee for the Ministry of Unification. She is also a member of the governing board of the Asia-Pacific Leadership Network (APLN) and a member of the Subcommittee on Energy and Just Transition of the Presidential Commission on Carbon Neutrality and Green Growth.
She received a B.A. from the University of Tokyo, an M.I.A. from Columbia University’s School of International and Public Affairs, and a Ph.D. from Johns Hopkins University’s School of Advanced International Studies.
Main Publications:
-“Multilateral Approach to the Back End of the Nuclear Fuel Cycle in Asia-Pacific?” Energy Policy Vol. 99 (2016): 158-164.
-“Energy and Climate Change Policies of Japan and South Korea,” in Ashley Esarey, Mary Alice Haddad, Joanna I. Lewis and Stevan Harrell Eds. Greening East Asia The Rise of the Eco-developmental State (Seattle: University of Washington Press, 2020).
-“A Comparative Study of Power Mixes for Green Growth: How South Korea and Japan See Nuclear Energy Differently,” Energies Vol.14, no. 18 (2021): 5681.
-“Japan’s Energy Security,” in Keiji Nakatsuji Ed. Japan’s Security Policy (Routledge, 2023).
-“The Emergence of Multipolarity and the Future of Alliances: Thinking about Sustainability of the Korea-US-Japan Strategic Triangle,” Korea Europe Review No. 7. DOI: https://doi.org/10.48770/ker.2025.no7.52. -
Michael Lim, M.D.
Stanford Medicine Endowed Chair of the Department of Neurosurgery, Professor of Neurosurgery and, by courtesy, of Radiation Oncology, of Medicine, of Otolaryngology - Head & Neck Surgery (OHNS) and of Neurology and Neurological Sciences
BioDr. Lim is the Chair of the Department of Neurosurgery and a board-certified neurosurgeon specializing in brain tumors and trigeminal neuralgia.
Dr. Lim’s clinical interests include the treatment of benign and malignant brain tumors, with special interest in gliomas, meningiomas, metastatic tumors, and skull base tumors. Dr. Lim also specializes in surgical treatments for trigeminal neuralgia. During his time at Johns Hopkins, Dr. Lim built one of the largest brain tumor and trigeminal neuralgia practices and utilized the most advanced surgical technologies and techniques for his patients. As a passionate voice for patient experience, he has been recognized by his peers and patients for his integrity and compassionate care, including a Service Excellence Award from HealthNetwork Foundation.
As a mentor, he has garnered numerous teaching awards, including being honored as an outstanding teacher by Johns Hopkins University School of Medicine. He is actively involved in shaping education for neurosurgery and oncology across the United States and around the world. He is the recipient of the prestigious 2023 Abhijit Guha Award in Neuro-Oncology.
Dr. Lim’s research interests focus on harnessing the immune system to fight cancer. His laboratory focuses on understanding mechanisms of immune evasion by cancer cells. He has successfully translated his findings from the laboratory to the clinics and has conducted and led several large national immunotherapy clinical trials for brain tumors.
Dr. Lim’s bibliography contains well over 300 articles on topics such as immunotherapy for glioblastoma, long-term survival of glioma patients treated with stereotactic radiation, and treatment of neuropathic pain. His work has appeared in Science Translational Medicine, Clinical Cancer Research, Lancet Oncology, Nature Immunology, and many more publications. He also has written 20 book chapters and monographs.
Dr. Lim is a world leader in immunotherapy for brain tumors. In addition to being invited world-wide to give lectures and seminars, he has given platform presentations on the topics of immunotherapy for brain tumors, neurosurgical techniques and management of brain tumors at the American Society of Clinical Oncologists, American Academy of Neurological Surgeons, Radiological Society of North America, Annual Symposium on Brain and Spine Metastases, Congress of Neurological Surgeons, and other meetings. In addition, he has served as platform chairman of the CNS session at the American Society for Clinical Oncology conference.
Dr. Lim is a member of the American Society for Clinical Oncology, Congress of Neurological Surgeons, American Association of Neurological Surgeons, and Society for Neuro-Oncology. Dr. Lim served as the program co-chair of the Society for Neuro-Oncology and CNS section of the American Society for Clinical Oncology. He also served on many executive committees, including the Executive Committee for the Joint Tumor Section of the American Association of Neurological Surgeons and Congress of Neurological Surgeons.
Trigeminal neuralgia treatment: https://www.youtube.com/watch?v=-n8nvwkwZik
Trigeminal neuralgia patient stories: https://www.youtube.com/watch?v=kClePRPYlQs&t=1s -
Feng Vankee Lin
Associate Professor of Psychiatry and Behavioral Sciences (Public Mental Health & Population Sciences)
Current Research and Scholarly InterestsMy career has been devoted to understanding the neural mechanisms involved in brain aging and brain plasticity, with a special focus on early detection and prevention of Alzheimer’s disease (AD). My research approach integrates principles and findings from cognitive theory, clinical neuroscience, and computational neuroscience.
-
Michael Lin
Professor of Neurobiology, of Bioengineering and, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsOur lab applies biochemical and engineering principles to the development of protein-based tools for investigating biology in living animals. Topics of investigation include fluorescent protein-based voltage indicators, synthetic light-controllable proteins, bioluminescent reporters, and applications to studying animal models of disease.
-
Yu Lin
Staff Scientist, Energy Sciences
BioDr. Lin is a staff scientist at SLAC National Accelerator Laboratory and a PI at the Stanford Institute for Materials and Energy Sciences (SIMES) at SLAC. Her research centers on utilizing a suite of in situ probes, particularly X-ray tools, to understand the behavior of complex materials under extreme conditions. These materials find applications in a wide range of technologies essential for a sustainable energy future. Recently, integrating artificial intelligence tools has become one of her new research endeavors, further advancing the study.
-
Aaron Lindenberg
Professor of Materials Science and Engineering and of Photon Science
BioLindenberg's research is focused on visualizing the ultrafast dynamics and atomic-scale structure of materials on femtosecond and picosecond time-scales. X-ray and electron scattering and spectroscopic techniques are combined with ultrafast optical techniques to provide a new way of taking snapshots of materials in motion. Current research is focused on the dynamics of phase transitions, ultrafast properties of nanoscale materials, and charge transport, with a focus on materials for information storage technologies, energy-related materials, and nanoscale optoelectronic devices.
-
Christian Linder
Professor of Civil and Environmental Engineering
BioChristian Linder is a Professor of Civil and Environmental Engineering and, by courtesy, of Mechanical Engineering. Through the development of novel and efficient in-house computational methods based on a sound mathematical foundation, the research goal of the Computational Mechanics of Materials (CM2) Lab at Stanford University, led by Dr. Linder, is to understand micromechanically originated multi-scale and multi-physics mechanisms in solid materials undergoing large deformations and fracture. Applications include sustainable energy storage materials, flexible electronics, and granular materials.
Dr. Linder received his Ph.D. in Civil and Environmental Engineering from UC Berkeley, an MA in Mathematics from UC Berkeley, an M.Sc. in Computational Mechanics from the University of Stuttgart, and a Dipl.-Ing. degree in Civil Engineering from TU Graz. Before joining Stanford in 2013 he was a Junior-Professor of Micromechanics of Materials at the Applied Mechanics Institute of Stuttgart University where he also obtained his Habilitation in Mechanics. Notable honors include a Fulbright scholarship, the 2013 Richard-von-Mises Prize, the 2016 ICCM International Computational Method Young Investigator Award, the 2016 NSF CAREER Award, and the 2019 Presidential Early Career Award for Scientists and Engineers (PECASE). -
Scott W Linderman
Assistant Professor of Statistics
BioScott Linderman, PhD, is an Assistant Professor at Stanford University in the Statistics Department and the Wu Tsai Neurosciences Institute, as well as the Co-Director of the Stanford Center for Neural Data Science. His research focuses on machine learning, computational neuroscience, and the general question of how computational and statistical methods can help to decipher neural computation. His work combines novel methodological development in the areas of state space models, deep generative models, point processes, and approximate Bayesian inference with applied statistical analyses of large-scale neural and behavioral data. Previously, he was a postdoctoral fellow at Columbia University and a graduate student at Harvard University. His work has been recognized with a Savage Award from the International Society for Bayesian Analysis, an AISTATS Best Paper Award, an NSF CAREER Award, and fellowships from the McKnight, Sloan, and Simons Foundations.
-
Malene Lindholm
Sr. Research Engineer, Medicine - Med/Cardiovascular Medicine
Current Research and Scholarly InterestsInterested in the genetics of human performance and the multi-omic response to exercise and training for optimizing human health.
-
Bruce Ling
Senior Research Scientist, Pediatrics - NeonatologyCurrent Research and Scholarly InterestsMy research focuses on developing AI-enabled translational medicine platforms that integrate real-world electronic health records, wearable biosensor signals, LC-MS/MS-based proteomics and metabolomics, cfDNA molecular profiling, and multimodal medical imaging. The overarching goal is to transform longitudinal clinical, physiological, and molecular data into predictive tools for early disease detection, dynamic risk stratification, digital twin modeling, and precision intervention.
-
Joseph (Joe) Lipsick
Professor of Pathology and of Genetics
Current Research and Scholarly InterestsFunction and evolution of the Myb oncogene family; function and evolution of E2F transcriptional regulators and RB tumor suppressors; epigenetic regulation of chromatin and chromosomes; cancer genetics.
-
Marc Lipsitch
Michael and Barbara Berberian Professor, Professor of Biology and Senior Fellow at the Freeman Spogli Institute for International Studies
BioMarc Lipsitch and his research group study the impact of medical and public health interventions and human immunity on pathogen populations and the consequences of these changes for human health. Within this broad umbrella we consider both ecological effects (modulating the amount of transmission and infection) and evolutionary ones (shaping the genetic composition of the populations of infectious agents). Specific areas of interest include natural selection imposed by strain-specific vaccines and antibiotics, design and evaluation of measures to control outbreaks and pandemics, methods for evaluating vaccine efficacy, and surveillance design. Tools include mathematical and computational modeling, pathogen population genomics, causal inference methods, and (in the past) experimental microbiology and immunology. In addition to this scientific research, we work in the areas of research ethics and biosecurity (through an appointment at the Center for International Security and Cooperation). He joined Stanford in 2026. From 1999-2025 he was a faculty member at Harvard TH Chan Schooll of Public Health, where he was Professor of Epidemiology (20062025) and founding Director of the Center for Communicable Disease Dynamics (2009-2025). He was founding Director for Science and then Senior Advisor at the CDC's Center for Forecasting and Outbreak Analytics (2021-5).
